Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?

Impact · against what's priced in

ALHC sees a bullish catalyst from strong projected YoY growth in earnings (85.7%) and revenues (29%), alongside planned market expansions in 2027. While the 25.1% rally reflects immediate optimism, the lack of upward EPS revisions suggests the market is still digesting the full scale of this growth.

ALHC+0.60

No priced-in read yet